chr16-288189-C-T

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_003502.4(AXIN1):​c.2522G>A​(p.Arg841Gln) variant causes a missense change. The variant allele was found at a frequency of 0.00913 in 1,613,706 control chromosomes in the GnomAD database, including 110 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0078 ( 11 hom., cov: 34)
Exomes 𝑓: 0.0093 ( 99 hom. )

Consequence

AXIN1
NM_003502.4 missense

Scores

4
14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 4.87
Variant links:
Genes affected
AXIN1 (HGNC:903): (axin 1) This gene encodes a cytoplasmic protein which contains a regulation of G-protein signaling (RGS) domain and a dishevelled and axin (DIX) domain. The encoded protein interacts with adenomatosis polyposis coli, catenin beta-1, glycogen synthase kinase 3 beta, protein phosphate 2, and itself. This protein functions as a negative regulator of the wingless-type MMTV integration site family, member 1 (WNT) signaling pathway and can induce apoptosis. The crystal structure of a portion of this protein, alone and in a complex with other proteins, has been resolved. Mutations in this gene have been associated with hepatocellular carcinoma, hepatoblastomas, ovarian endometriod adenocarcinomas, and medullablastomas. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0047746897).
BP6
Variant 16-288189-C-T is Benign according to our data. Variant chr16-288189-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 774502.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 1186 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AXIN1NM_003502.4 linkc.2522G>A p.Arg841Gln missense_variant Exon 11 of 11 ENST00000262320.8 NP_003493.1 O15169-1A0A0S2Z4R0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AXIN1ENST00000262320.8 linkc.2522G>A p.Arg841Gln missense_variant Exon 11 of 11 1 NM_003502.4 ENSP00000262320.3 O15169-1
AXIN1ENST00000354866.7 linkc.2414G>A p.Arg805Gln missense_variant Exon 10 of 10 1 ENSP00000346935.3 O15169-2
AXIN1ENST00000461023.5 linkn.5591G>A non_coding_transcript_exon_variant Exon 8 of 8 2
AXIN1ENST00000457798.1 linkc.*27G>A downstream_gene_variant 3 ENSP00000416835.1 H0Y830

Frequencies

GnomAD3 genomes
AF:
0.00779
AC:
1186
AN:
152204
Hom.:
11
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00142
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00530
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00103
Gnomad FIN
AF:
0.0309
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0103
Gnomad OTH
AF:
0.00527
GnomAD2 exomes
AF:
0.00842
AC:
2111
AN:
250678
AF XY:
0.00856
show subpopulations
Gnomad AFR exome
AF:
0.00161
Gnomad AMR exome
AF:
0.00257
Gnomad ASJ exome
AF:
0.000199
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.0345
Gnomad NFE exome
AF:
0.0101
Gnomad OTH exome
AF:
0.00866
GnomAD4 exome
AF:
0.00927
AC:
13542
AN:
1461384
Hom.:
99
Cov.:
31
AF XY:
0.00921
AC XY:
6693
AN XY:
726984
show subpopulations
African (AFR)
AF:
0.00173
AC:
58
AN:
33480
American (AMR)
AF:
0.00284
AC:
127
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000153
AC:
4
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.00182
AC:
157
AN:
86258
European-Finnish (FIN)
AF:
0.0345
AC:
1827
AN:
52936
Middle Eastern (MID)
AF:
0.000867
AC:
5
AN:
5768
European-Non Finnish (NFE)
AF:
0.00980
AC:
10899
AN:
1111994
Other (OTH)
AF:
0.00768
AC:
464
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
868
1736
2604
3472
4340
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
396
792
1188
1584
1980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00779
AC:
1186
AN:
152322
Hom.:
11
Cov.:
34
AF XY:
0.00850
AC XY:
633
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.00142
AC:
59
AN:
41574
American (AMR)
AF:
0.00529
AC:
81
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00103
AC:
5
AN:
4832
European-Finnish (FIN)
AF:
0.0309
AC:
328
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0103
AC:
702
AN:
68014
Other (OTH)
AF:
0.00521
AC:
11
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
61
122
182
243
304
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00863
Hom.:
18
Bravo
AF:
0.00585
TwinsUK
AF:
0.00863
AC:
32
ALSPAC
AF:
0.00830
AC:
32
ESP6500AA
AF:
0.000681
AC:
3
ESP6500EA
AF:
0.0115
AC:
99
ExAC
AF:
0.00840
AC:
1020
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00916
EpiControl
AF:
0.00848

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Dec 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

AXIN1: BP4, BS2 -

Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Caudal duplication;C2239176:Hepatocellular carcinoma Benign:1
Oct 18, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.39
T;.
Eigen
Benign
0.15
Eigen_PC
Benign
0.034
FATHMM_MKL
Uncertain
0.97
D
LIST_S2
Uncertain
0.89
D;T
MetaRNN
Benign
0.0048
T;T
MetaSVM
Benign
-0.93
T
MutationAssessor
Uncertain
2.3
M;.
PhyloP100
4.9
PrimateAI
Benign
0.43
T
PROVEAN
Benign
-1.1
N;N
REVEL
Benign
0.16
Sift
Benign
0.12
T;T
Sift4G
Benign
0.30
T;T
Polyphen
1.0
D;D
Vest4
0.23
MVP
0.59
MPC
0.90
ClinPred
0.026
T
GERP RS
4.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.43
gMVP
0.56
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34015754; hg19: chr16-338189; COSMIC: COSV51989077; COSMIC: COSV51989077; API